TY - JOUR
T1 - Pharmacokinetics and Penetration into the Aqueous Humor of Long Action Oxytetracycline after Single Dose Intravenous and Intramuscular Administrations in Rabbits
AU - Koc, Feride AU - Kaynar, Ozgur AU - Okumus, Zafer AU - Dogan, Elif AU - Yanmaz, Latif Emrah
JO - Journal of Animal and Veterinary Advances
VL - 8
IS - 10
SP - 1900
EP - 1905
PY - 2009
DA - 2001/08/19
SN - 1680-5593
DO - javaa.2009.1900.1905
UR - https://makhillpublications.co/view-article.php?doi=javaa.2009.1900.1905
KW - Oxytetracycline
KW -rabbit
KW -aqueous humor
KW -pharmacokinetics
KW -plasma
KW -intravenous
AB - The aim of this study was to investigate pharmacokinetics and penetration into the aqueous humor of Long Action Oxytetracycline (OTC-LA) after Intravenous (IV) and Intramuscular (IM) administrations, at a single dose of 20 mg kg-1 b.wt in rabbits. After administrations of the long action formulation, the plasma oxytetracycline concentrations were evaluated using a two-compartmental open model. The study was designed according to a two-period cross-over and the plasma OTC concentration was measured using the ELISA procedure. The elimination half-lives (t1/2β) of the OTC-LA after IV and IM administrations were 12.60±0.92 and 38.67±4.40 h, respectively. After IV administration, the volume of distribution (Vdss) and total body Clearance (Cltot) values of the drug were 3.42±0.21 L kg-1 and 0.19±0.01 L/h/kg, respectively. The maximum concentration of the drug (Cmax) in the plasma (4.23±0.43 μg mL-1) was achieved at 2.0 h (tmax) after IM administration. The Minimum therapeutic plasma Concentration (MIC) of the drug at the amount ≥0.5 μg mL-1 was maintained until 48 h after IV and IM administrations. The intramuscular bioavailability of the drug was 0.79±0.10%. After IV and IM administrations of OTC-LA formulation, the maximum concentrations of the drug in the aqueous humor were 0.1 and 0.068 μg mL-1, respectively. However, the concentrations of the drug in the aqueous humor were below the MIC value (0.5 μg mL-1) during 12-72 and 4-48 h for IM and IV administrations, respectively.
ER -